文献速递药物不良反应与药物警戒

EudraVigilance 中自发报告的用药错误案例特征分析

Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilance.
PubMed 文献 · Drug Saf · 2017-01-01

本研究基于 EudraVigilance 数据库 2002–2015 年自发报告的用药错误案例,通过 MedDRA 用药错误 SMQ 检索并分类。共检索到 147,824 例报告,其中 41,355 例来自欧洲经济区(EEA);报告绝对数与占 EudraVigilance 总报告比例在研究期间上升,EEA 来源案例在 2005 年和 2012 年前后出现峰值。

要点

  • 2005–2015 年 EudraVigilance 用药错误自发报告持续增加。
  • 约 60% 案例通过窄 SMQ 检索获得。
  • 儿童用药错误报告中近半集中于 2 月至 2 岁。

核心结论

  • EudraVigilance 中用药错误自发报告在 2005 至 2015 年间持续增加,原因可能为多因素。

研究设计与样本

  • 研究检索 2002–2015 年 EudraVigilance 自发报告,以 MedDRA 用药错误 SMQ 识别案例并按 MedDRA 术语、地区、年龄组和 ATC 分类。

主要发现

  • 共检索到 147,824 例用药错误报告,其中 41,355 例来自欧洲经济区(EEA)。
  • 约 60% 的报告通过窄 SMQ 检索获得。
  • 报告绝对数和占 EudraVigilance 总报告比例在研究期间增加,EEA 来源案例在 2005 年和 2012 年前后出现峰值。
  • 儿童报告中近一半为 2 个月至 2 岁。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Medication errors recently became the focus of regulatory guidance in pharmacovigilance to support reporting, evaluation and prevention of medication errors. OBJECTIVE: This study aims to characterise spontaneously reported cases of medication errors in EudraVigilance over the period 2002-2015 before the release of EU good practice guidance. METHODS: Case reports were identified through the adverse reaction section where a Medical Dictionary for Regulatory Activities (MedDRA®) term is reported and included in the Standardised MedDRA® Query (SMQ) for medication errors. These case reports were further categorised by MedDRA® terms, geographical region, patient age group and Anatomical Therapeutic Chemical classification system of suspect medicinal product(s). RESULTS: A total of 147,824 case reports were retrieved, 41,355 of which were from the European Economic Area (EEA). Approximately 60% of these case reports were retrieved with the narrow SMQ. The absolute number of medication error case reports and the proportion to the total number of reports in EudraVigilance increased during the study period, with peaks seen around 2005 and 2012 for cases with EEA origin. Fifty-two percent of case reports in which age was provided occurred in adults, 30% in the elderly and 18% in children, with almost half of these in children aged 2 months to 2 years. CONCLUSION: Case reports of medication errors in EudraVigilance steadily increased between 2005 and 2015, the reasons for which may be multifactorial, including increased awareness, changes to the MedDRA® terminology and the 2012 EU pharmacovigilance legislation and associated guidance for stakeholders, or a generally increased risk for errors as more medications become available.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Newbould V, Le Meur S, Goedecke T, et al. Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilance. Drug Saf. 2017. PMID: 28698988. doi:10.1007/s40264-017-0569-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。